Literature DB >> 12452316

Plasma hepatocyte growth factor and the relationship between risk factors and carotid atherosclerosis.

Yoshikuni Yamamoto1, Katsuhiko Kohara, Yasuharu Tabara, Michiya Igase, Jun Nakura, Tetsuro Miki.   

Abstract

Hepatocyte growth factor (HGF) has been shown to have a unique stimulating property on the endothelium as well as an anti-apoptotic action on the endothelium. Through these mechanisms, HGF has been shown to have an anti-atherogenic action in animal models. In atherosclerotic disorders, the circulating level of HGF has been shown to be increased to compensate for its decline in tissue. However, whether increased circulating HGF has any influence on the development of atherosclerosis has not been elucidated. In the present study, the association between plasma HGF concentration and the risk factor-carotid atherosclerosis relationship was evaluated. Three hundred and seventeen community-dwelling subjects participated in the study. The plasma concentration of HGF was determined by enzyme-linked immunosorbent assay (ELISA). The subjects were divided into two groups according to the plasma level of HGF: a low HGF group (n=199, plasma HGF < 150 pg/ml) and a high HGF group (n=118, plasma HGF > or = 150 pg/ml). Risk factors for atherosclerosis were evaluated in each subject. Carotid ultrasonography was performed to measure carotid arterial intima-media thickness (IMT) and the presence of plaque. The association between carotid IMT and risk factors was then evaluated in the two HGF groups. The regression lines between age and carotid IMT were significantly different between the low HGF and high HGF groups (F[1,313]=5.98, p=0.015). The regression lines between systolic blood pressure and carotid IMT were also significantly different between the two HGF groups (F[1,313]=5.17, p=0.024). A general linear model showed that the interaction between age and plasma level of HGF was significantly associated with carotid IMT, suggesting that the plasma level of HGF modifies the age-related increase in carotid IMT. In addition, clustering of risk factors was evaluated in subjects with carotid atherosclerosis. The number of total risk factors in carotid atherosclerosis subjects with high plasma HGF was significantly greater than that in those with low HGF, even though the two groups had a similar magnitude of carotid atherosclerosis. In conclusion, these findings indicate that risk factor-dependent augmentation of carotid atherosclerosis could be influenced by circulating HGF.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12452316     DOI: 10.1291/hypres.25.661

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  4 in total

1.  Hepatocyte growth factor and the risk of ischemic stroke developing among postmenopausal women: results from the Women's Health Initiative.

Authors:  Swapnil N Rajpathak; Tao Wang; Sylvia Wassertheil-Smoller; Howard D Strickler; Robert C Kaplan; Aileen P McGinn; Rachel P Wildman; Daniel Rosenbaum; Thomas E Rohan; Philipp E Scherer; Mary Cushman; Gloria Y F Ho
Journal:  Stroke       Date:  2010-03-04       Impact factor: 7.914

2.  Hepatocyte growth factor demonstrates racial heterogeneity as a biomarker for coronary heart disease.

Authors:  Suzette J Bielinski; Cecilia Berardi; Paul A Decker; Nicholas B Larson; Elizabeth J Bell; James S Pankow; Michele M Sale; Weihong Tang; Naomi Q Hanson; Christina L Wassel; Mariza de Andrade; Matthew J Budoff; Joseph F Polak; Hugues Sicotte; Michael Y Tsai
Journal:  Heart       Date:  2017-06-01       Impact factor: 5.994

3.  Circulating Hepatocyte Growth Factor Reflects Activation of Vascular Repair in Response to Stress.

Authors:  Yihong Chen; Junyan Shen; Anna Hultgårdh Nilsson; Isabel Goncalves; Andreas Edsfeldt; Gunnar Engström; Suneela Zaigham; Olle Melander; Marju Orho-Melander; Uwe Rauch; Shreenidhi M Venuraju; Avijit Lahiri; Chun Liang; Jan Nilsson
Journal:  JACC Basic Transl Sci       Date:  2022-07-20

4.  Hepatocyte growth factor and carotid intima-media thickness in relation to circulating CD34-positive cell levels.

Authors:  Yuji Shimizu; Shimpei Sato; Jun Koyamatsu; Hirotomo Yamanashi; Mako Nagayoshi; Shin-Ya Kawashiri; Keita Inoue; Shoichi Fukui; Hideaki Kondo; Seiko Nakamichi; Yasuhiro Nagata; Takahiro Maeda
Journal:  Environ Health Prev Med       Date:  2018-05-03       Impact factor: 3.674

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.